TCP Analytical Company Profile

Background

Overview

TCP Analytical Holdings, LLC is a leading manufacturer and distributor of specialty chemicals, reagents, and consumable products utilized in life science applications. The company serves a diverse clientele across North America, including sectors such as biotechnology, pharmaceuticals, clinical and academic research, and industrial markets. With a comprehensive portfolio of over 50,000 SKUs, TCP Analytical aims to be a one-stop solution for its customers and distributors.

Mission and Vision

TCP Analytical is dedicated to simplifying research and production processes, enhancing reliability, and accelerating scientific discovery. By offering innovative custom solutions, dependable performance, and exceptional customer service, the company strives to support research and development across various industries.

Industry Significance

Operating within the life sciences and chemical manufacturing industries, TCP Analytical plays a pivotal role in providing essential products that underpin critical testing and production processes. Its extensive product range and commitment to quality make it a significant contributor to advancements in scientific research and industrial applications.

Key Strategic Focus

Core Objectives

TCP Analytical focuses on expanding its market presence through strategic acquisitions and organic growth initiatives. The company aims to enhance its product offerings, diversify its customer base, and strengthen its position in the life sciences sector.

Areas of Specialization

The company specializes in the manufacturing and distribution of specialty chemicals, reagents, and consumable products essential for analytical testing labs and production operations. Its product portfolio includes a wide array of items catering to various scientific and industrial needs.

Key Technologies Utilized

TCP Analytical employs advanced manufacturing processes and quality control measures to ensure the reliability and performance of its products. The company leverages industry best practices and technological innovations to meet the evolving demands of its diverse clientele.

Primary Markets Targeted

The company's primary markets include biotechnology and pharmaceutical companies, clinical and academic research institutions, and industrial sectors requiring specialized chemicals and laboratory products. TCP Analytical's extensive product range positions it to serve a broad spectrum of industries and applications.

Financials and Funding

Funding History

As of March 25, 2025, TCP Analytical secured a significant investment from Audax Strategic Capital, a provider of customized, mid-hold equity solutions. This investment was intended to support the company's future mergers and acquisitions (M&A) and organic growth initiatives. Existing investors, including Riverarch Equity Partners, The Hillman Company, Lacy Diversified, PPM America, and others, also committed substantial incremental capital to TCP Analytical.

Total Funds Raised

The exact total funds raised by TCP Analytical are not publicly disclosed. However, the March 2025 funding round was a significant event, indicating strong investor confidence in the company's growth prospects.

Notable Investors

Audax Strategic Capital: Led the March 2025 investment round, providing customized equity solutions to support TCP Analytical's growth initiatives.

Riverarch Equity Partners: A middle-market private equity firm that has been a long-time sponsor of TCP Analytical, supporting its growth through multiple acquisitions.

The Hillman Company: Participated in the March 2025 funding round, contributing to the company's expansion efforts.

Lacy Diversified: Invested in TCP Analytical, supporting its strategic growth initiatives.

PPM America: Contributed to the funding round, aiding in the company's expansion and development.

Utilization of Capital

The capital raised is intended to bolster TCP Analytical's M&A program and support continued funding from its long-time sponsor, Riverarch Equity Partners. This financial backing is expected to facilitate the company's growth through strategic acquisitions and organic initiatives.

Pipeline Development

Key Pipeline Candidates

TCP Analytical has expanded its product offerings through strategic acquisitions, including the purchase of Alconox, LLC, a leading provider of laboratory cleaning solutions. This acquisition enhances TCP Analytical's capabilities in delivering comprehensive solutions to its customers.

Stages of Development

The company is in the integration phase of its recent acquisitions, focusing on aligning operations and leveraging synergies to enhance product offerings and market reach.

Target Conditions

TCP Analytical's acquisitions aim to address the growing demand for high-quality laboratory products and solutions, particularly in the life sciences sector.

Anticipated Milestones

The company anticipates achieving operational synergies and expanded market presence through its recent acquisitions, with ongoing efforts to integrate and optimize its expanded portfolio.

Technological Platform and Innovation

Proprietary Technologies

TCP Analytical's portfolio includes proprietary technologies developed by its subsidiary companies, such as Burrell Scientific's Wrist Action® Shaker, a laboratory device known for its reliability and performance.

Significant Scientific Methods

The company employs advanced manufacturing processes and quality control measures to ensure the reliability and performance of its products. This includes the use of high-purity chemicals and specialized equipment to meet the stringent requirements of scientific research and industrial applications.

Leadership Team

Executive Profiles

Al Jurgela: Chief Executive Officer (CEO) of TCP Analytical, leading the company's strategic direction and growth initiatives.

Michael Rost: Managing Director at Riverarch Equity Partners, involved in supporting TCP Analytical's growth through strategic investments.

Kumber Husain: Managing Director at Audax Strategic Capital, leading the investment in TCP Analytical to support its growth initiatives.

Competitor Profile

Market Insights and Dynamics

The market for specialty chemicals and laboratory products is characterized by steady growth, driven by advancements in biotechnology, pharmaceuticals, and industrial applications. Companies in this sector compete on product quality, innovation, and customer service.

Competitor Analysis

Key competitors to TCP Analytical include Sealweld, Inovatas, and Martin Specialty Products. These companies offer similar products and services, contributing to a competitive landscape in the specialty chemicals and laboratory products market.

Strategic Collaborations and Partnerships

Significant Collaborations

TCP Analytical has expanded its capabilities through strategic acquisitions, such as the purchase of Alconox, LLC, enhancing its product offerings in laboratory cleaning solutions.

Partnerships

The company collaborates with various industry leaders and investors to support its growth initiatives and enhance its market presence.

Operational Insights

Strategic Considerations

TCP Analytical's strategic focus on acquisitions and organic growth positions it to leverage synergies and expand its market footprint. The company's diverse product portfolio and commitment to quality provide a competitive advantage in serving a broad range of industries.

Strategic Opportunities and Future Directions

Growth Roadmap

The company plans to continue its expansion through strategic acquisitions and organic growth, aiming to enhance its product offerings and market reach. TCP Analytical's strong financial backing and experienced leadership team support its strategic objectives.

Future Business Directions

TCP Analytical is focused on integrating its recent acquisitions, optimizing operations, and delivering comprehensive solutions to its customers. The company is committed to maintaining high standards of quality and customer service as it expands its market presence.